APP-BUTINACA is an analytical reference standard that is structurally similar to known synthetic cannabinoids. This product is intended for research and forensic applications.
- Product Name: APP-B
- IUPAC Name: (S)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-butyl-1H-indazole-3-carboxamide
- Other Names: APP-BINACA
- Molecular Formula: C21H24N4O2
- Appearance: Crystal and powder
- Application: Research purposes
- Availability: In Stock
- Packaging: Aluminum foil bag package done by expert
- Purity: 98.8%
- Origin: China
- Minimum order: 10 Grams
- Production Capacity: 100KG/WEEK
- Transportation: Delivery done by EMS, DHL, FEDEX, UPS and TNT
JWH 018 is a synthetic cannabinoid (CB) that potently activates the central CB1 and peripheral CB2 receptors (Ki = 9.0 and 2.94 nM, respectively).This cannabimimetic compound has frequently been found in herbal blends. JWH 018 is distinguished by a terminal epoxide group on the alkyl chain. The biological and toxicological properties of this compound have not been characterized. This product is intended for forensic and research purposes.
SGT151 has been known as a synthetic cannabinoid. It has been found in Spice-like herbal blends.This product is intended for research and forensic purposes.
4-cyano CUMYL-BUTINACA is an analytical reference standard that is structurally categorized as a synthetic cannabinoid. The physiological and toxicological properties of this compound are not known. 4-cyano CUMYL-BUTINACA is regulated as a Schedule I compound in the United States. This product is intended for forensic and research applications.
U-48800 is structurally similar to known opioids and possesses similar characteristics. This product is intended for research and forensic purposes.
TH-PVP / A-PHP / A-PVP is a powerful synthetic stimulant drug which functions as a norepinephrine-dpamine reuptake inhibitor (NDRI), being roughly a quarter the potency of MDPV the effects are said to be comparable. Use with caution.
3MEO PCP3MEO PCP
Phencyclidine (PCP), known more commonly as angel dust, is a psychoactive drug that is regulated as a schedule I compound in the United States. 3-MEO-PCP is an analog of PCP which binds the NMDA receptor (Ki = 20 nM) and serotonin transporter (Ki = 216 nM) with greater affinity than does PCP (Ki = 59 and 2,234 nM, respectively). The toxicological properties of this compound have not been reported. This product is intended for forensic and research purposes.